Management of severe dengue in children

Advances in Experimental Medicine and Biology

Volumn 609, Issue , 2008, Pages 131-144

  Moxon, Christopher ^a   Wills, Bridget ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARBAZOCHROME; CORTICOSTEROID; DESMOPRESSIN ACETATE; FRESH FROZEN PLASMA; HEMOSTATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ASSISTED VENTILATION; BED REST; BLEEDING; BLOOD TRANSFUSION; CLINICAL FEATURE; CLINICAL TRIAL; COLLOID; CONFERENCE PAPER; CRYSTALLOID; DENGUE; DENGUE SHOCK SYNDROME; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG EFFICACY; FLUID RESUSCITATION; GASTRITIS; HUMAN; IMMUNOPATHOLOGY; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REYE SYNDROME; THROMBOCYTOPENIA; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; CHILD; DENGUE VIRUS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VIROLOGY;

CHILD; DENGUE; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; HUMANS;

EID: 39149085372     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-73960-1_10     Document Type: Conference Paper

References (44)

1. Alderson P, Schierhout G, Roberts I, and Bunn F. (2000). Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev, (2):CD000567.
2. Bethell DB, Flobbe K, and Cao XT, et al. (1998). Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis, 177(3):778-782.
3. Bethell DB, Gamble J, and Pham PL, et al. (2001). Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever. Clin Infect Dis, 32(2):243-253.
4. Bhamarapravati N. (1997). Pathology of infection. In Gubler DJ and Kuno G (eds.), Dengue and Dengue Hemorrhagic Fever. CAB International, Wallingford, pp. 115-132.
5. Bokisch VA, Top FH, Jr., Russell PK, Dixon FJ, and Muller-Eberhard HJ. (1973). The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med, 289(19):996-1000.
6. Chiu YC, Wu KL, and Kuo CH, et al. (2005). Endoscopic findings and management of dengue patients with upper gastrointestinal bleeding. Am J Trop Med Hyg, 73(2):441-I44.
7. Chuansumrit A, Tangnararatchakit K, and Lektakul Y, et al. (2004). The use of recombinant activated factor VII for controlling life-threatening bleeding in dengue shock syndrome. Blood Coagul Fibrinolysis, 15(4):335-342.
8. Chuansumrit A, Wangruangsatid S, Lektrakul Y, Chua MN, Zeta Capeding MR, and Bech OM. (2005). Control of bleeding in children with dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study. Blood Coagul Fibrinolysis, 16(8):549-555.
9. Chungue E, Poli L, Roche C, Gestas P, Glaziou P, and Markoff LI (1994). Correlation between detection of plasminogen cross-reactive antibodies and hemorrhage in dengue virus infection. J Infect Dis, 170(5): 1304-1307.
10. Deen JL, Harris E, and Wills B, et al. (2006). The WHO dengue classification and case definitions: time for a reassessment. Lancet, 368(9530): 170-173.
11. Dung NM, Day NP, and Tarn DT, et al. (1999). Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens. Clin Infect Dis, 29(4):787-794.
12. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, and Norton R. (2004). A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med, 350(22):2247-2256.
13. Gamble J, Gartside IB, and Christ F. (1993). A reassessment of mercury in silastic strain gauge plethysmography for microvascular permeability assessment in man. J Physiol, 464:407-422.
14. Green S, Vaughn DW, and Kalayanarooj S, et al. (1999). Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis, 179(4):755-762.
15. Griffel MI and Kaufman BS. (1992). Pharmacology of colloids and crystalloids. Crit Care Clin, 8(2):235-253.
16. Gubler DJ. (1998). Dengue and dengue hemorrhagic fever. Clin Microbiol Rev, 11(3):480-496.
17. Halstead SB and O'Rourke EJ. (1977). Antibody-enhanced dengue virus infection in primate leukocytes. Nature, 265(5596):739-741.
18. Halstead SB, Nimmannitya S, and Cohen SN. (1970). Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med, 42(5):311-328.
19. Harris E, Videa E, and Perez L, et al. (2000). Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg, 63(1-2):5-11.
20. Haupt MT, Kaufman BS, and Carlson RW (1992). Fluid resuscitation in patients with increased vascular permeability. Crit Care Clin, 8(2):341-353.
21. Leitmeyer KC, Vaughn DW, and Watts DM, et al. (1999). Dengue virus structural differences that correlate with pathogenesis. J Virol, 73(6):4738-4747.
22. Markoff LJ, Innis BL, Houghten R, and Henchal LS. (1991). Development of cross-reactive antibodies to plasminogen during the immune response to dengue virus infection. J Infect Dis, 164(2):294-301.
23. Michel CC and Curry FE. (1999). Microvascular permeability. Physiol Rev, 79(3):703-761.
24. Mongkolsapaya J, Dejnirattisai W, and Xu XN, et al. (2003). Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med, 9(7):921-927.
25. Ngo NT, Cao XT, and Kneen R, et al. (2001). Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis, 32(2):204-213.
26. Pea L, Roda L, and Moll F. (2001). Desmopressin treatment for a case of dengue hemorrhagic fever/dengue shock syndrome. Clin Infect Dis, 33(9): 1611-1612.
27. Petchclai B and Saelim P. (1978). Circulating immune complexes in dengue haemorrhagic fever. Lancet, 2(8090):638-639.
28. Phuong CX, Nhan NT, and Kneen R, et al. (2004). Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the world health organization classification system helpful? Am J Trop Med Hyg, 70(2): 172-179.
29. Rico-Hesse R, Harrison LM, and Salas RA, et al. (1997). Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology, 230(2):244-251.
30. Rigau-Perez JG and Bonilla GL. (1999). An evaluation of modified case definitions for the detection of dengue hemorrhagic fever. Puerto Rico Association of Epidemiologists. P R Health Sci J, 18(4):347-352.
31. Rosen L, Drouet MT, and Deubel V. (1999). Detection of dengue virus RNA by reverse transcription-polymerase chain reaction in the liver and lymphoid organs but not in the brain in fatal human infection. Am J Trop Med Hyg, 61(5):720-724.
32. Schierhout G and Roberts I. (1998). Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ, 316(7136):961-964.
33. Srichaikul T and Nimmannitya S. (2000). Haematology in dengue and dengue haemorrhagic fever. Baillieres Best Pract Res Clin Haematol, 13(2):261-276.
34. Sumarmo, Talogo W, Asrin A, Isnuhandojo B, and Sahudi A. (1982). Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics, 69(1):45-49.
35. Tassniyom S, Vasanawathana S, Chirawatkul A, and Rojanasuphot S. (1993). Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics, 92(1): 111-115.
36. Tassniyom S, Vasanawathana S, Dhiensiri T, Nisalak A, and Chirawatkul A. (1997). Failure of carbazochrome sodium sulfonate (AC-17) to prevent dengue vascular permeability or shock: a randomized, controlled trial. J Pediatr, 131(4):525-528.
37. Tsai CJ, Kuo CH, Chen PC, and Changcheng CS. (1991). Upper gastrointestinal bleeding in dengue fever. Am J Gastroenterol, 86(1):33-35.
38. Wang W, Chao D, and Kao CL, et al. (2003). High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology, 305(2):330-338.
39. Webb AR. (2000). The appropriate role of colloids in managing fluid imbalance: a critical review of recent meta-analytic findings. Crit Care, 4(Suppl 2):S26-S32. Epub 2000 Oct 13.
40. WHO. (1997). Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. World Health Organisation, Geneva.
41. Wills BA, Oragui EE, and Stephens AC, et al. (2002). Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome. Clin Infect Dis, 35(3):277-285.
42. Wills BA, Oragui EE, and Dung NM, et al. (2004). Size and charge characteristics of the protein leak in dengue shock syndrome. J Infect Dis, 190(4):810-818.
43. Wills BA, Nguyen MD, and Ha TL, et al. (2005). Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med, 353(9):877-889.
44. Wu SJ, Grouard-Vogel G, and Sun W, et al. (2000). Human skin Langerhans cells are targets of dengue virus infection. Nat Med, 6(7):816-820.